TABLE 2.
HSV prevalence in mucocutaneous specimens by patient age
| Age (yr) |
illumigene HSV 1 |
illumigene HSV 2 |
||||
|---|---|---|---|---|---|---|
| Total no. | Total no. positivea | Prevalence (%)b | Total no. | Total no. positivea | Prevalence (%)b | |
| ≤5 | 47 | 8 | 17.0 | 47 | 0 | 0.0 |
| 6 to 18 | 81 | 17 | 21.0 | 81 | 15 | 18.5 |
| 19 to 55 | 627 (1) | 137 | 21.8 | 628 | 138 | 22.0 |
| >55 | 91 (2) | 21 | 23.1 | 92 (1) | 16 | 17.4 |
| Not provided | 3 | 0 | 0.0 | 2 (1) | 0 | 0.0 |
a
Positivity was calculated based on the illumigene results.
b
Specimens resulting in invalid results were removed for prevalence analysis (no.).